IceCure Medical Ltd. (NASDAQ: ICCM)
$0.76
+0.0009 ( +0.12% ) 20.6K
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Market Data
Open
$0.76
Previous close
$0.76
Volume
20.6K
Market cap
$36.27M
Day range
$0.76 - $0.79
52 week range
$0.52 - $1.57
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Apr 03, 2024 |
6-k | Quarterly Reports | 2 | Apr 02, 2024 |
6-k | Quarterly Reports | 2 | Mar 19, 2024 |
6-k | Quarterly Reports | 2 | Mar 12, 2024 |
6-k | Quarterly Reports | 2 | Mar 04, 2024 |
6-k | Quarterly Reports | 2 | Feb 26, 2024 |
6-k | Quarterly Reports | 2 | Jan 30, 2024 |
6-k | Quarterly Reports | 4 | Jan 12, 2024 |
6-k | Quarterly Reports | 2 | Jan 12, 2024 |
6-k | Quarterly Reports | 2 | Jan 10, 2024 |